The classical model of PD pathophysiology exploits the opposing effects of dopamine on striatopallidal (Drd2) and striatonigral (Drd1a) medium spiny neurons (MSNs) to explain the clinical features of bradykinesia, rigidity, and akinesia (Albin et al., 1989). Here, DRD2 is linked to Parkinson disease.